‌

US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents

Patent 7265131 was granted and assigned to Exelixis on September, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

September 4, 2007

Patent Application Number

10738964

Date Filed

December 17, 2003

Patent Citations Received

US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies

0

US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide

0

US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject

0

US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

0

US Patent 11759525 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies

US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness

US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies

0

...

Patent Primary Examiner

Patent abstract

Compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7265131 Isoquinolinone derivatives and their use as therapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool